Viridian Therapeutics Inc (VRDN NASDAQ) stock market data APIs
$14.8618
0.44(3%)
as of April 10, 2026
Try our APIs with
free plan!
Viridian Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.
Prev. Close
14.8618
Open
15.2978
High
15.3376
Low
14.6718
52 wk Range
11.76-34.29
Market Cap
1 528 M
Shares Outstanding
102 M
Revenue
70 849 K
EPS
-1.08
Beta
1.165
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Viridian Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Viridian Therapeutics Inc data using free add-ons & libraries
Get Viridian Therapeutics Inc Fundamental Data
Viridian Therapeutics Inc Fundamental data includes:
- Net Revenue: 70 849 K
- EBITDA: -362 935 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-05
- EPS/Forecast: -0.9558
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Viridian Therapeutics Inc News
New
Viridian Therapeutics price target lowered to $36 from $40 at Truist
Truist lowered the firm’s price target on Viridian Therapeutics (VRDN) to $36 from $40 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 earnings in Biotech. Reac...
Viridian Metals Secures $225,000 Maximum JEA Funding; Adopts Quarterly Reporting Exemption
OTTAWA, April 08, 2026 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) (“Viridian” or the “Company”) reports that it has been awarded $225,000 under the Junior Exploration Assistance (...
Stifel sees path towards differentiation for Viridian after Amgen data
Stifel analyst Alex Thompson notes that Amgen (AMGN) announced positive topline results for the Phase 3 on-body infusion study of Tepezza achieving a 77% rate of proptosis response, which comes in hig...
AMGN's Subcutaneous Tepezza Scores Phase III Win in Thyroid Eye Disease
Amgen AMGN announced positive top-line results from a late-stage study evaluating the subcutaneous (under the skin or SC) formulation of its blockbuster drug Tepezza (teprotumumab) in patients with mo...
Get Viridian Therapeutics Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
